Retina experts David Eichenbaum, MD, and Michael S. Ip, MD, discuss the undertreatment and management of patients with neovascular age-related macular degeneration, including therapeutic options, patient populations that might benefit from specific treatment modalities, how to address complications, and likely outcomes based on published evidence.
Special Collections
Clinician Viewpoints
Retina experts Mitul Mehta, MD, and SriniVas Sadda, MD, discuss the management of neovascular age-related macular degeneration, including therapeutic options, patient populations that might benefit from specific treatment modalities, how to address complications, and likely outcomes based on published evidence.